Crossref journal-article
Elsevier BV
Journal of Pharmaceutical Sciences (78)
Bibliography

Lysik, M. A., & Wu-Pong, S. (2003). Innovations in Oligonucleotide Drug Delivery. Journal of Pharmaceutical Sciences, 92(8), 1559–1573.

Authors 2
  1. Melanie A. Lysik (first)
  2. Susanna Wu-Pong (additional)
References 124 Referenced 75
  1. 10.1073/pnas.75.1.280 / Proc Natl Acad Sci USA / Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide by Zamecnik (1978)
  2. 10.1073/pnas.75.1.285 / Proc Natl Acad Sci USA / Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide by Stephenson (1978)
  3. 10.1016/S0076-6879(00)13003-4 / Methods Enzymol / Progress in antisense technology: the end of the beginning by Crooke (2000)
  4. 10.1023/A:1016281324761 / Pharm Res / Antigene, ribozyme and aptamer nucleic acid drugs: Progress and prospects by Stull (1995)
  5. 10.1016/0167-4781(90)90031-V / Biochim Biophys Acta / Specific regulation of gene expression by antisense, sense and antigene nucleic acids by Helene (1990)
  6. 10.1016/S0264-410X(98)00151-0 / Vaccine / CpG motifs as immune adjuvants by Klinman (1999)
  7. {'key': '10.1002/jps.10399_bb0040', 'first-page': '105', 'article-title': 'CpG oligonucleotides as immune adjuvants', 'volume': '30', 'author': 'Krieg', 'year': '2000', 'journal-title': 'Ernst Schering Res Found Workshop'} / Ernst Schering Res Found Workshop / CpG oligonucleotides as immune adjuvants by Krieg (2000)
  8. 10.1016/S0264-410X(00)00249-8 / Vaccine / Immune effects and mechanisms of action of CpG motifs by Krieg (2000)
  9. 10.1073/pnas.94.20.10833 / Proc Natl Acad Sci USA / Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization by Weiner (1997)
  10. 10.1073/pnas.85.4.1028 / Proc Natl Acad Sci USA / Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA by Wickstrom (1988)
  11. 10.1089/ard.1992.2.27 / Antisense Res Dev / Oligodeoxyribonucleotide phosphorothioate fluxes and localization in hematopoietic cells by Marti (1992)
  12. {'key': '10.1002/jps.10399_bb0065', 'first-page': '67', 'article-title': 'Minimally modified oligonucleotides-combination of end-capping and pyrimidine-protection', 'volume': '377', 'author': 'Peyman', 'year': '1996', 'journal-title': 'Biol Chem Hoppe Seyler'} / Biol Chem Hoppe Seyler / Minimally modified oligonucleotides-combination of end-capping and pyrimidine-protection by Peyman (1996)
  13. 10.1089/oli.1.1997.7.345 / Antisense Nucleic Acid Drug Dev / Studies on the mechanism of stabilization of partially phosphorothioated oligonucleotides against nucleolytic degradation by Uhlmann (1997)
  14. 10.1089/oli.1.1998.8.35 / Antisense Nucleic Acid Drug Dev / Impact of 3′-exonuclease stereoselectivity on the kinetics of phosphorothioate oligonucleotide metabolism by Gilar (1998)
  15. 10.1093/nar/19.20.5543 / Nucleic Acids Res / Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages by Shoji (1991)
  16. 10.1073/pnas.86.17.6454 / Proc Natl Acad Sci USA / Mechanism of oligonucleotide uptake by cells: Involvement of specific receptors? by Yakubov (1989)
  17. 10.1073/pnas.86.10.3474 / Proc Natl Acad Sci USA / Characterization of oligonucleotide transport into living cells by Loke (1989)
  18. 10.1073/pnas.91.8.3156 / Proc Natl Acad Sci USA / Electron micrographic studies of transport of oligodeoxynucleotides across eukaryotic cell membranes by Zamecnik (1994)
  19. 10.1089/ard.1995.5.175 / Antisense Res Dev / The uptake and distribution of phosphorothioate oligonucleotides into vascular smooth muscle cells in vitro and in rabbit arteries by Farrell (1995)
  20. 10.1021/bi00069a022 / Biochemistry / Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells by Stein (1993)
  21. 10.1023/A:1015846209681 / Pharm Res / Antisense c-myc oligodeoxyribonucleotide cellular uptake by Wu-Pong (1992)
  22. 10.1089/ard.1994.4.155 / Antisense Res Dev / Antisense c-myc oligonucleotide cellular uptake and activity by Wu-Pong (1994)
  23. 10.1111/j.1768-322X.1997.tb01013.x / Biol Cell / Oligonucleotide biological activity: Relationship to the cell cycle and nuclear transport by Wu-Pong (1997)
  24. 10.1016/S0169-409X(00)00084-3 / Adv Drug Deliv Rev / Alternative interpretations of the oligonucleotide transport literature: Insights from nature by Wu-Pong (2000)
  25. 10.1080/07328319908044826 / Nucleosides Nucleotides / Uptake of oligonucleotides by keratinocytes by Laktionov (1999)
  26. 10.1111/1523-1747.ep12371683 / J Invest Dermatol / Characteristics of oligonucleotide uptake in human keratinocyte cultures by Noonberg (1993)
  27. 10.1089/ard.1992.2.211 / Antisense Res Dev / Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells by Iversen (1992)
  28. {'key': '10.1002/jps.10399_bb0145', 'first-page': '1091', 'article-title': 'Rapid nuclear accumulation of injected oligodeoxyribonucleotides', 'volume': '2', 'author': 'Chin', 'year': '1990', 'journal-title': 'New Biol'} / New Biol / Rapid nuclear accumulation of injected oligodeoxyribonucleotides by Chin (1990)
  29. 10.1073/pnas.88.7.2702 / Proc Natl Acad Sci USA / Intracellular distribution of microinjected antisense oligonucleotides by Leonetti (1991)
  30. 10.1159/000053277 / Horm Res / Development of efficient transient transfection systems for introducing antisense oligonucleotides into human epithelial skin cells by Fimmel (2000)
  31. 10.1016/S0005-2736(99)00209-6 / Biochim Biophys Acta / A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability by Stuart (2000)
  32. 10.1016/0166-3542(94)90039-6 / Antiviral Res / Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 mRNA in CaSki cells by Lappalainen (1994)
  33. 10.1016/0005-2736(94)00224-X / Biochim Biophys Acta / Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells by Lappalainen (1994)
  34. 10.1073/pnas.93.21.11493 / Proc Natl Acad Sci USA / Mechanism of oligonucleotide release from cationic liposomes by Zelphati (1996)
  35. 10.1111/j.1749-6632.1994.tb21701.x / Ann NY Acad Sci / Cationic liposomes for direct gene transfer in therapy of cancer and other diseases by Farhood (1994)
  36. 10.1016/0005-2736(94)90017-5 / Biochim Biophys Acta / Oligonucleotide-cationic liposome interactions. A physicochemical study by Jaaskelainen (1994)
  37. 10.1093/nar/20.21.5691 / Nucleic Acids Res / Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity by Thierry (1992)
  38. 10.1006/bbrc.1993.2552 / Biochem Biophys Res Commun / Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum by Capaccioli (1993)
  39. 10.1016/S0005-2736(98)00046-7 / Biochim Biophys Acta / Delivery of an anti-HIV-1 ribozyme into HIV-infected cells via cationic liposomes by Konopka (1998)
  40. 10.1093/nar/29.10.2079 / Nucleic Acids Res / Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: Down-regulation of the corticotropin-releasing factor receptor by Shi (2001)
  41. 10.1023/A:1015836829670 / Pharm Res / Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: Comparison with cationic liposomes by Legendre (1992)
  42. 10.1016/0006-291X(92)90565-3 / Biochem Biophys Res Commun / Oligonucleotides encapsulated in pH sensitive liposomes are efficient toward Friend retrovirus by Ropert (1992)
  43. 10.1046/j.1432-1327.2000.01255.x / Eur J Biochem / Inhibition of inositol uptake in astrocytes by antisense oligonucleotides delivered by pH-sensitive liposomes by Lubrich (2000)
  44. {'key': '10.1002/jps.10399_bb0225', 'first-page': '1129', 'article-title': 'In vivo delivery of antisense oligonucleotides in pH-sensitive liposomes inhibits lipopolysaccharide-induced production of tumor necrosis factor-α in rats', 'volume': '297', 'author': 'Ponnappa', 'year': '2001', 'journal-title': 'J Pharmacol Exp Ther'} / J Pharmacol Exp Ther / In vivo delivery of antisense oligonucleotides in pH-sensitive liposomes inhibits lipopolysaccharide-induced production of tumor necrosis factor-α in rats by Ponnappa (2001)
  45. 10.1126/science.281.5373.78 / Science / An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery by Koltover (1998)
  46. 10.1021/bi00445a027 / Biochemistry / Small, but not large, unilamellar liposomes composed of dioleoylphosphatidylethanolamine and oleic acid can be stabilized by human plasma by Liu (1989)
  47. 10.1002/(SICI)1097-0215(19980831)77:5<728::AID-IJC11>3.0.CO;2-Y / Int J Cancer / Delivery to cancer cells of antisense L-myc oligonucleotides incorporated in fusogenic, cationic-lipid-reconstituted influenza-virus envelopes (cationic virosomes) by Waelti (1998)
  48. 10.1016/S0006-2952(96)00763-0 / Biochem Pharmacol / Scavenger receptor-mediated delivery of antisense mini-exon phosphorothioate oligonucleotide to Leishmania-infected macrophages. Selective and efficient elimination of the parasite by Chaudhuri (1997)
  49. 10.1073/pnas.92.8.3318 / Proc Natl Acad Sci USA / Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol by Wang (1995)
  50. 10.1093/jnci/92.3.253 / J Natl Cancer Inst / Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: Antitumor effects by Pagnan (2000)
  51. 10.1016/S0166-3542(96)00993-X / Antiviral Res / Inhibition of HIV replication by immunoliposomal antisense oligonucleotide by Selvam (1996)
  52. 10.1016/S0145-2126(96)00062-8 / Leuk Res / Enhanced delivery of synthetic oligonucleotides to human leukaemic cells by liposomes and immunoliposomes by Ma (1996)
  53. 10.1093/nar/22.20.4307 / Nucleic Acids Res / Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms by Zelphati (1994)
  54. 10.1016/0166-3542(94)90090-6 / Antiviral Res / Synthesis and anti-HIV activity of thiocholesteryl-coupled phosphodiester antisense oligonucleotides incorporated into immunoliposomes by Zelphati (1994)
  55. 10.1089/ard.1993.3.323 / Antisense Res Dev / Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes by Zelphati (1993)
  56. 10.1073/pnas.87.7.2448 / Proc Natl Acad Sci USA / Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication by Leonetti (1990)
  57. {'key': '10.1002/jps.10399_bb0290', 'first-page': '29', 'article-title': 'Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells', 'volume': '17', 'author': 'Ginobbi', 'year': '1997', 'journal-title': 'Anticancer Res'} / Anticancer Res / Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells by Ginobbi (1997)
  58. 10.1016/S0076-6879(99)14113-2 / Methods Enzymol / Targeted delivery of antisense oligonucleotides to parenchymal liver cells in vivo by Biessen (2000)
  59. 10.1042/bj3400783 / Biochem J / Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo by Biessen (1999)
  60. 10.1016/S0021-9258(18)53118-5 / J Biol Chem / Binding-incompetent adenovirus facilitates molecular conjugate-mediated gene transfer by the receptor-mediated endocytosis pathway by Michael (1993)
  61. {'key': '10.1002/jps.10399_bb0310', 'first-page': '463', 'article-title': 'Targeted polynucleotides for inhibition of hepatitis B and C viruses', 'volume': '42', 'author': 'Wu', 'year': '2001', 'journal-title': 'Croat Med J'} / Croat Med J / Targeted polynucleotides for inhibition of hepatitis B and C viruses by Wu (2001)
  62. 10.1016/S0021-9258(18)42295-8 / J Biol Chem / Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides by Wu (1992)
  63. 10.1093/nar/22.24.5439 / Nucleic Acids Res / Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers by Chiou (1994)
  64. 10.1016/0005-2736(95)00237-5 / Biochim Biophys Acta / Oligonucleotide targeting to alveolar macrophages by mannose receptor- mediated endocytosis by Liang (1996)
  65. 10.1074/jbc.271.18.10560 / J Biol Chem / Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system by Fominaya (1996)
  66. 10.1073/pnas.87.11.4033 / Proc Natl Acad Sci USA / Transferrin-polycation-mediated introduction of DNA into human leukemic cells: Stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels by Cotten (1990)
  67. 10.1073/pnas.87.9.3410 / Proc Natl Acad Sci USA / Transferrin-polycation conjugates as carriers for DNA uptake into cells by Wagner (1990)
  68. {'key': '10.1002/jps.10399_bb0345', 'first-page': '206', 'article-title': 'Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system', 'volume': '276', 'author': 'Wu', 'year': '1996', 'journal-title': 'J Pharmacol Exp Ther'} / J Pharmacol Exp Ther / Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system by Wu (1996)
  69. 10.4049/jimmunol.163.8.4421 / J Immunol / An antibody-avidin fusion protein specific for the transferrin receptor serves as a delivery vehicle for effective brain targeting: Initial applications in anti-HIV antisense drug delivery to the brain by Penichet (1999)
  70. 10.1016/S0049-3848(97)00027-3 / Thromb Res / Suppression of human monocyte tissue factor synthesis by antisense oligodeoxynucleotide by Stephens (1997)
  71. 10.1023/A:1016073132320 / Pharm Res / Enhanced cellular uptake of oligonucleotides by EGF receptor-mediated endocytosis in A549 cells by Deshpande (1996)
  72. 10.1021/bc980004h / Bioconjug Chem / Use of Nalpha-Fmoc-cysteine(S-thiobutyl) derivatized oligodeoxynucleotides for the preparation of oligodeoxynucleotide- peptide hybrid molecules by Soukchareun (1998)
  73. 10.1021/bc00031a004 / Bioconjug Chem / Preparation and characterization of antisense oligonucleotide-peptide hybrids containing viral fusion peptides by Soukchareun (1995)
  74. 10.1093/nar/25.14.2730 / Nucleic Acids Res / A new peptide vector for efficient delivery of oligonucleotides into mammalian cells by Morris (1997)
  75. 10.1093/nar/22.22.4681 / Nucleic Acids Res / Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide by Bongartz (1994)
  76. {'key': '10.1002/jps.10399_bb0385', 'first-page': '841', 'article-title': 'Modified adenovirus penton base protein (UTARVE) as a non-replicating vector for delivery of antisense oligonucleotides with antiviral and/or antineoplastic activity', 'volume': '17', 'author': 'Smith', 'year': '2000', 'journal-title': 'Int J Oncol'} / Int J Oncol / Modified adenovirus penton base protein (UTARVE) as a non-replicating vector for delivery of antisense oligonucleotides with antiviral and/or antineoplastic activity by Smith (2000)
  77. 10.1042/bj3540671 / Biochem J / Delivery of oligonucleotides into mammalian cells by anionic peptides: Comparison between monomeric and dimeric peptides by Freulon (2001)
  78. 10.1021/bc990046l / Bioconjug Chem / Synthesis and binding properties of oligonucleotides carrying nuclear localization sequences by de La Torre (1999)
  79. 10.1021/bc010068j / Bioconjug Chem / Protamine-fragment peptides fused to an sv40 nuclear localization signal deliver oligonucleotides that produce antisense effects in prostate and bladder carcinoma cells by Benimetskaya (2002)
  80. 10.1006/bbrc.1997.8050 / Biochem Biophys Res Commun / Design of carrier peptide-oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties by Chaloin (1998)
  81. 10.1021/bc980133y / Bioconjug Chem / Peptide-oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties by Antopolsky (1999)
  82. 10.1021/bc00031a012 / Bioconjug Chem / Synthesis and evaluation of nuclear targeting peptide-antisense oligodeoxynucleotide conjugates by Reed (1995)
  83. 10.1016/S0169-409X(00)00082-X / Adv Drug Deliv Rev / Novel non-endocytic delivery of antisense oligonucleotides by Dokka (2000)
  84. 10.1016/0167-4781(94)90054-X / Biochim Biophys Acta / DNA uptake stimulating protein from Neurospora crassa enhances DNA and oligonucleotide uptake also in mammalian cells by Toth (1994)
  85. 10.1016/S0006-2952(00)00310-5 / Biochem Pharmacol / Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates by Astriab-Fisher (2000)
  86. 10.1615/CritRevTherDrugCarrierSyst.v12.i4.20 / Crit Rev Ther Drug Carrier Syst / Cyclodextrin derivatives in pharmaceutics by Albers (1995)
  87. {'key': '10.1002/jps.10399_bb0440', 'first-page': '231', 'article-title': 'The potential use of cyclodextrins in parenteral formulations', 'volume': '43', 'author': 'Brewster', 'year': '1989', 'journal-title': 'J Parenter Sci Technol'} / J Parenter Sci Technol / The potential use of cyclodextrins in parenteral formulations by Brewster (1989)
  88. 10.1002/jps.2600811116 / J Pharm Sci / Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble β-cyclodextrin derivatives and formulation as oleaginous suppository by Arima (1992)
  89. 10.1023/A:1015896405389 / Pharm Res / Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats by Merkus (1991)
  90. 10.1089/ard.1995.5.185 / Antisense Res Dev / Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery by Zhao (1995)
  91. 10.1007/s007050050182 / Arch Virol / β-Cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence by Abdou (1997)
  92. 10.1089/oli.1.2000.10.469 / Antisense Nucleic Acid Drug Dev / Downregulation of the p75 neurotrophin receptor in tissue culture and in vivo, using β-cyclodextrin-adamantane-oligonucleotide conjugates by Epa (2000)
  93. 10.1016/S0006-2952(96)00555-2 / Biochem Pharmacol / Modulation of oligonucleotide-induced immune stimulation by cyclodextrin analogs by Zhao (1996)
  94. 10.1093/nar/28.21.4225 / Nucleic Acids Res / Enhanced delivery of antisense oligonucleotides with fluorophore- conjugated PAMAM dendrimers by Yoo (2000)
  95. {'key': '10.1002/jps.10399_bb0480', 'first-page': '3606', 'article-title': 'Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice', 'volume': '7', 'author': 'Sato', 'year': '2001', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice by Sato (2001)
  96. 10.1080/07328319908044833 / Nucleosides Nucleotides / Uptake and intracellular distribution of oligonucleotides vectorized by a PAMAM dendrimer by Helin (1999)
  97. 10.1016/S0006-2952(99)00083-0 / Biochem Pharmacol / Cell cycle-dependent distribution and specific inhibitory effect of vectorized antisense oligonucleotides in cell culture by Helin (1999)
  98. 10.1093/nar/24.11.2176 / Nucleic Acids Res / Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers by Bielinska (1996)
  99. 10.1002/jps.2600681215 / J Pharm Sci / Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum by Couvreur (1979)
  100. 10.1111/j.2042-7158.1979.tb13510.x / J Pharm Pharmacol / Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: Preparation, morphological and sorptive properties by Couvreur (1979)
  101. 10.1023/A:1018923301967 / Pharm Res / Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake by Chavany (1994)
  102. 10.1073/pnas.91.22.10460 / Proc Natl Acad Sci USA / Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice by Schwab (1994)
  103. 10.1023/A:1015871809313 / Pharm Res / Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides by Chavany (1992)
  104. 10.1006/meth.1999.0786 / Methods / Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers by Zimmer (1999)
  105. 10.1016/S0378-5173(00)00624-4 / Int J Pharm / Polyisobutylcyanoacrylate nanocapsules containing an aqueous core for the delivery of oligonucleotides by Lambert (2001)
  106. 10.1006/bbrc.2000.3963 / Biochem Biophys Res Commun / EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumor in mice by Lambert (2000)
  107. 10.1023/A:1016017014573 / Pharm Res / Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice by Nakada (1996)
  108. 10.1002/jps.10063 / J Pharm Sci / Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes by De Rosa (2002)
  109. 10.1016/S0168-3659(00)00299-6 / J Controlled Release / Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres by Freytag (2000)
  110. 10.3109/10611869808995882 / J Drug Target / Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotide: Characterization of P(LA-GA) copolymer microspheres in vitro by Lewis (1998)
  111. 10.1016/S0378-5173(98)00085-4 / Int J Pharm / Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation by Regnier (1999)
  112. 10.3109/10611869808995881 / J Drug Target / Parameters controlling topical delivery of oligonucleotides by electroporation by Regnier (1998)
  113. 10.1023/A:1011963318843 / Pharm Res / Localization of a FITC-labeled phosphorothioate oligodeoxynucleotide in the skin after topical delivery by iontophoresis and electroporation by Regnier (1998)
  114. 10.1002/(SICI)1097-0215(20000115)85:2%3C260::AID-IJC18%3E3.0.CO;2-R / Int J Cancer / In vivo electroporetic transfer of bcl-2 antisense oligonucleotide inhibits the development of hepatocellular carcinoma in rats by Baba (2000)
  115. 10.1006/bbrc.1995.1968 / Biochem Biophys Res Commun / Transdermal transport of DNA antisense oligonucleotides by electroporation by Zewert (1995)
  116. 10.1002/jps.2600840803 / J Pharm Sci / Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin by Oldenburg (1995)
  117. 10.1182/blood.V88.2.731.bloodjournal882731 / Blood / Electroporation of synthetic oligodeoxynucleotides: A novel technique for ex vivo bone marrow purging by Bergan (1996)
  118. 10.1073/pnas.96.11.6411 / Proc Natl Acad Sci USA / Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues by Mann (1999)
  119. 10.1089/10430349950017004 / Hum Gene Ther / A pressure-mediated nonviral method for efficient arterial gene and oligonucleotide transfer by von der Leyen (1999)
  120. 10.1007/s001090100204 / J Mol Med / Shock waves: A novel method for cytoplasmic delivery of antisense oligonucleotides by Tschoep (2001)
  121. {'key': '10.1002/jps.10399_bb0610', 'first-page': '219', 'article-title': 'In vivo transfection of melanoma cells by lithotripter shock waves', 'volume': '58', 'author': 'Bao', 'year': '1998', 'journal-title': 'Cancer Res'} / Cancer Res / In vivo transfection of melanoma cells by lithotripter shock waves by Bao (1998)
  122. 10.1089/hum.1996.7.11-1339 / Hum Gene Ther / Ultrasound-mediated transfection of mammalian cells by Kim (1996)
  123. 10.1097/00004424-199712000-00001 / Invest Radiol / Ultrasound enhances gene expression of liposomal transfection by Unger (1997)
  124. 10.1016/S0301-5629(99)00099-X / Ultrasound Med Biol / A comparison of shock wave and sinusoidal-focused ultrasound-induced localized transfection of HeLa cells by Huber (1999)
Dates
Type When
Created 22 years, 1 month ago (July 23, 2003, 6:12 a.m.)
Deposited 2 years, 3 months ago (April 26, 2023, 2 p.m.)
Indexed 2 months, 3 weeks ago (June 4, 2025, 7:44 a.m.)
Issued 22 years ago (Aug. 1, 2003)
Published 22 years ago (Aug. 1, 2003)
Published Print 22 years ago (Aug. 1, 2003)
Funders 0

None

@article{Lysik_2003, title={Innovations in Oligonucleotide Drug Delivery}, volume={92}, ISSN={0022-3549}, url={http://dx.doi.org/10.1002/jps.10399}, DOI={10.1002/jps.10399}, number={8}, journal={Journal of Pharmaceutical Sciences}, publisher={Elsevier BV}, author={Lysik, Melanie A. and Wu-Pong, Susanna}, year={2003}, month=aug, pages={1559–1573} }